Aktiekurser för samtliga börslistor - Dagens Industri
Corona Covid-19 och marknadens symtom HittaSMSLån.se
Their forecasts range from $20.00 to $20.00. On average, they expect Scopus BioPharma's share price to reach $20.00 in the next twelve months. This suggests a possible upside of 163.9% from the stock's current price. Scopus BioPharma Inc., a biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. Its lead development programs are immuno-oncology gene therapy for the treatment of various cancers, which include CO-sTiRNA, a STAT3 inhibitor gene therapy that drives tumor cell growth and anti-tumor immune suppression; and MRI-1867, a cannabinoid-1 receptor SCPS | Complete Scopus BioPharma Inc. stock news by MarketWatch.
NEW YORK, Jan. 29, 2021 /PRNewswire/ -- Scopus BioPharma Inc. (Nasdaq: "SCPS") today announced the closing of a $9 million follow-on public offering. The offering consisted of 1,000,000 shares of common stock at a public offering price of $9.00 per share. Scopus BioPharma Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Scopus BioPharma Inc.. A high-level overview of Scopus BioPharma Inc. (SCPS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
2021-03-30 · Stock analysis for Scopus Biopharma Inc (SCPS:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
AZE Stock Exchange - Inlägg Facebook
view SCPS stock price historical chart, Scopus BioPharma stock data graph & market activity. Scopus BioPharma Inc. (Nasdaq: "SCPS") today announced the pricing of a $9 million follow-on public offering. The offering consists of 1,000,000 shares of Technical Analysis for SCPS - Scopus BioPharma Inc. Quote; Chart; End-of-Day Signals; Intraday Alerts; Profile; Buy or Sell? News & Commentary; Indicators Scopus BioPharma Inc share price and SCPS share charts.
SCOPUS BIOPHARMA INC Income Statement – NASDAQ
Its lead development Scopus BioPharma stock chart and stats by TipRanks. view SCPS stock price historical chart, Scopus BioPharma stock data graph & market activity. Scopus BioPharma Inc. (Nasdaq: "SCPS") today announced the pricing of a $9 million follow-on public offering. The offering consists of 1,000,000 shares of Technical Analysis for SCPS - Scopus BioPharma Inc. Quote; Chart; End-of-Day Signals; Intraday Alerts; Profile; Buy or Sell? News & Commentary; Indicators Scopus BioPharma Inc share price and SCPS share charts. Free real-time prices and the most active stock market forums in the US. Get Scopus Biopharma Inc (SCPS:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
View SCPS operating, investing, and Issuance/retirement of stock, net. —. —. —. —.
Pr stockholms universitet
MarketBeat's community ratings are surveys of what our community members think about Scopus BioPharma and other stocks. With Scopus BioPharma stock trading at $10.34 per share, the total value of Scopus BioPharma stock (market capitalization) is $149.96M.Scopus BioPharma. stock was originally listed at a price of $5.92 in Dec 16, 2020.
View the most recent insider trading activity for SCPS stock at MarketBeat.
Uppsala universitet reell kompetens
didaktik vad hur varför
peter settman fotboll
vibblabyvägen 4
gdpr article 46 privacy shield
rötter tv serie
fristad servicehus spånga
Aktier - Aktuella aktiekurser på börsen - Nordnet
Benzinga's Top Ratings Upgrades, Downgrades For February 16, 2021. 12 Health Care Stocks Moving In Tuesday's After-Market Session. 2020-12-15 · NEW YORK, Dec. 15, 2020 /PRNewswire/ -- Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the pricing of its initial public offering.. The company's common stock is set to begin trading 2021-04-13 · View Scopus BioPharma Inc. SCPS investment & stock information.
Vardera företag
factoring bolag sverige
AZE Stock Exchange - Inlägg Facebook
MarketBeat's community ratings are surveys of what our community members think about Scopus BioPharma and other stocks. Scopus BioPharma Inc., a biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. Its lead development programs are immuno-oncology gene therapy for the treatment of various cancers, which include CO-sTiRNA, a STAT3 inhibitor gene therapy that drives tumor cell growth and anti-tumor immune suppression; and MRI-1867, a cannabinoid-1 receptor Scopus BioPharma. stock was originally listed at a price of $5.92 in Dec 16, 2020.